| Title |
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, September 2011
|
| DOI | 10.1136/annrheumdis-2011-200350 |
| Pubmed ID | |
| Authors |
L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Cañete, M de Wit, H Dagfinrud, K de Vlam, M Dougados, P Helliwell, A Kavanaugh, T K Kvien, R Landewé, T Luger, M Maccarone, D McGonagle, N McHugh, I B McInnes, C Ritchlin, J Sieper, P P Tak, G Valesini, J Vencovsky, K L Winthrop, A Zink, P Emery |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 20% |
| Bulgaria | 1 | 10% |
| Venezuela, Bolivarian Republic of | 1 | 10% |
| United Kingdom | 1 | 10% |
| Argentina | 1 | 10% |
| Mexico | 1 | 10% |
| Mauritius | 1 | 10% |
| Unknown | 2 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 70% |
| Science communicators (journalists, bloggers, editors) | 2 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 288 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| Japan | 2 | <1% |
| United Kingdom | 2 | <1% |
| Netherlands | 1 | <1% |
| Australia | 1 | <1% |
| Paraguay | 1 | <1% |
| Finland | 1 | <1% |
| Brazil | 1 | <1% |
| Singapore | 1 | <1% |
| Other | 3 | 1% |
| Unknown | 273 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 51 | 18% |
| Other | 43 | 15% |
| Student > Master | 32 | 11% |
| Student > Ph. D. Student | 27 | 9% |
| Student > Bachelor | 23 | 8% |
| Other | 75 | 26% |
| Unknown | 37 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 178 | 62% |
| Agricultural and Biological Sciences | 15 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 2% |
| Nursing and Health Professions | 7 | 2% |
| Business, Management and Accounting | 5 | 2% |
| Other | 30 | 10% |
| Unknown | 46 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2022.
All research outputs
#3,730,849
of 25,998,826 outputs
Outputs from Annals of the Rheumatic Diseases
#2,167
of 7,902 outputs
Outputs of similar age
#19,651
of 146,982 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#11
of 90 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,902 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,982 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.